GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » RenovaCare Inc (OTCPK:RCAR) » Definitions » Shiller PE Ratio

RenovaCare (RenovaCare) Shiller PE Ratio : (As of May. 14, 2024)


View and export this data going back to . Start your Free Trial

What is RenovaCare Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


RenovaCare Shiller PE Ratio Historical Data

The historical data trend for RenovaCare's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RenovaCare Shiller PE Ratio Chart

RenovaCare Annual Data
Trend Dec12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

RenovaCare Quarterly Data
Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of RenovaCare's Shiller PE Ratio

For the Biotechnology subindustry, RenovaCare's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RenovaCare's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, RenovaCare's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where RenovaCare's Shiller PE Ratio falls into.



RenovaCare Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

RenovaCare's E10 for the quarter that ended in Sep. 2022 is calculated as:

For example, RenovaCare's adjusted earnings per share data for the three months ended in Sep. 2022 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Sep. 2022 (Change)*Current CPI (Sep. 2022)
=-0.005/125.2265*125.2265
=-0.005

Current CPI (Sep. 2022) = 125.2265.

RenovaCare Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201212 0.000 96.871 0.000
201303 0.000 98.209 0.000
201306 0.000 98.518 0.000
201309 0.000 98.790 0.000
201312 -0.011 98.326 -0.014
201403 -0.004 99.695 -0.005
201406 -0.010 100.560 -0.012
201409 -0.020 100.428 -0.025
201412 -0.004 99.070 -0.005
201503 -0.004 99.621 -0.005
201506 -0.003 100.684 -0.004
201509 -0.004 100.392 -0.005
201512 -0.010 99.792 -0.013
201603 -0.010 100.470 -0.012
201606 -0.010 101.688 -0.012
201609 -0.004 101.861 -0.005
201612 -0.010 101.863 -0.012
201703 -0.010 102.862 -0.012
201706 -0.020 103.349 -0.024
201709 -0.010 104.136 -0.012
201712 -0.010 104.011 -0.012
201803 -0.010 105.290 -0.012
201806 -0.010 106.317 -0.012
201809 -0.010 106.507 -0.012
201812 -0.010 105.998 -0.012
201903 -0.010 107.251 -0.012
201906 -0.010 108.070 -0.012
201909 -0.010 108.329 -0.012
201912 -0.010 108.420 -0.012
202003 -0.010 108.902 -0.011
202006 -0.030 108.767 -0.035
202009 -0.030 109.815 -0.034
202012 -0.030 109.897 -0.034
202103 -0.010 111.754 -0.011
202106 -0.010 114.631 -0.011
202109 -0.020 115.734 -0.022
202112 -0.010 117.630 -0.011
202203 -0.020 121.301 -0.021
202206 -0.030 125.017 -0.030
202209 -0.005 125.227 -0.005

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


RenovaCare  (OTCPK:RCAR) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


RenovaCare Shiller PE Ratio Related Terms

Thank you for viewing the detailed overview of RenovaCare's Shiller PE Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


RenovaCare (RenovaCare) Business Description

Traded in Other Exchanges
N/A
Address
9375 East Shea Boulvard, Suite 107-A, Scottsdale, AZ, USA, 85260
RenovaCare Inc is a biotechnology company focusing on the acquisition, research, development and commercialization of autologous cellular therapies that can be used for medical and aesthetic applications. The company's initial products under development target skin. It offers treatment methodology for cell isolation for the regeneration of human skin cells, along with a medical-grade liquid spraying device and associated equipment (the SkinGun). RenovaCare is evaluating the efficacy and potential of SkinGun, in combination with a cell isolation method, in the treatment of tissue that has been subject to severe trauma. Geographically all the activities are functioned through the region of United States.
Executives
Patsy Trisler officer: Vice President 430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Thomas Bold officer: President & CEO 430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Joseph Sierchio director 430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Kenneth Kirkland director 430 PARK AVENUE, SUITE 702, NEW YORK NY 10022
Rhonda Beth Rosen director, officer: President & CEO 43 DICKINSON ROAD, BASKING RIDGE NJ 07920
1420525 Alberta Ltd. 10 percent owner 1628 WEST 1ST AVENUE, SUITE 216, VANCOUVER A1 V6J1G1
David E Jenkins director 406 NORTH HERMOSA DRIVE, PALM SPRINGS CA 92262
Antonino G Cacace director, officer: President CRUD-Y-GWYNT, CASWELL BAY, SWANSEA X0 SA3 3BU
Jeet Sidhu director 5667 SUNRISE CRESCENT WEST, SURREY, BC A1 V3S 7M4
Derek Cooper officer: President/ CEO
Frank J Fabio officer: CFO/Sec.(Resigned 1/9/2009) 670 BROADWAY, MASSAPEQUA NY 11758
Christian F Hudson director 33 CHURCHILL ROAD, TENAFLY NJ 07670
Harmel S Rayat director, 10 percent owner 700 - 688 WEST HASTINGS STREET, VANCOUVER A1 V6B 1P1
Stanley Wong officer: President/CEO
Terri Dumoulin director, officer: Secretary/Treasurer

RenovaCare (RenovaCare) Headlines

From GuruFocus

RenovaCare Announces Management Changes

By GuruFocusNews GuruFocusNews 03-24-2022

RenovaCare Announces Termination of StemCell Systems R&D Agreement

By GuruFocusNews GuruFocusNews 05-03-2022